Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

BACKGROUND: In major depressive disorder (MDD), treatment persistence is critical to optimize symptom remission, functional recovery, and health care costs. Desvenlafaxine tends to have fewer drug interactions and better tolerability than other MDD drugs; however, its use has not been assessed in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Solem, Caitlyn T, Shelbaya, Ahmed, Wan, Yin, Deshpande, Chinmay G, Alvir, Jose, Pappadopulos, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087821/
https://www.ncbi.nlm.nih.gov/pubmed/27822048
http://dx.doi.org/10.2147/NDT.S115094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087821/
https://www.ncbi.nlm.nih.gov/pubmed/27822048
http://dx.doi.org/10.2147/NDT.S115094

Ejemplares similares